Financhill
Sell
22

EDIT Quote, Financials, Valuation and Earnings

Last price:
$1.27
Seasonality move :
-11.28%
Day range:
$1.28 - $1.38
52-week range:
$1.28 - $11.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.74x
P/B ratio:
0.62x
Volume:
4.2M
Avg. volume:
2.9M
1-year change:
-87.17%
Market cap:
$108.1M
Revenue:
$78.1M
EPS (TTM):
-$2.56

Earnings Data

Next earnings date for EDIT
Feb 28
2025
Most recent earnings per share
-$0.75
Beat by $0.02
(Nov 4/2024)
Consensus Estimate
-$0.77
(Nov 4/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EDIT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $36M -- -- -$0.36 --
11/04/2024 Q3 $3.9M $61K -$0.75 -$0.77 $0.02
08/07/2024 Q2 $4.1M $513K -$0.82 -$0.71 -$0.11
05/08/2024 Q1 $7.3M $1.1M -$0.76 -$0.64 -$0.12
02/28/2024 Q4 $14.3M $60M -$0.23 -$0.48 $0.25
11/03/2023 Q3 -- -- -$0.55 -$0.58 $0.03
08/02/2023 Q2 -- -- -$0.56 -$0.77 $0.21
05/05/2023 Q1 -- -- -$0.71 -$0.81 $0.10
02/22/2023 Q4 -- -- -$0.88 -$0.81 -$0.07
11/02/2022 Q3 -- -- -$0.81 -$0.85 $0.04
08/03/2022 Q2 -- -- -$0.78 -$0.80 $0.02
05/04/2022 Q1 -- -- -$0.74 -$0.79 $0.05
02/24/2022 Q4 -- -- -$0.61 -$0.73 $0.12
11/08/2021 Q3 -- -- -$0.57 -$0.81 $0.24
08/04/2021 Q2 -- -- -$0.81 -$0.81 $0.00
05/05/2021 Q1 -- -- -$0.86 -$0.71 -$0.15
02/25/2021 Q4 -- -- -$1.00 -$0.88 -$0.12
11/05/2020 Q3 -- -- $0.12 -$0.63 $0.75
08/06/2020 Q2 -- -- -$0.43 -$0.82 $0.39
05/07/2020 Q1 -- -- -$0.69 -$0.81 $0.12
02/26/2020 Q4 -- -- -$0.74 $0.06 -$0.80
11/12/2019 Q3 -- -- -$0.66 -$0.73 $0.07
08/06/2019 Q2 -- -- -- -$0.62 --
05/07/2019 Q1 -- -- -- -$0.64 --
02/28/2019 Q4 -- -- -- -$0.55 --
11/07/2018 Q3 -- -- -- -$0.81 --
08/06/2018 Q2 -- -- -- -- --
05/03/2018 Q1 -- -- -- -- --
03/06/2018 Q4 -- -- -- -- --
11/07/2017 Q3 -- -- -- -- --
08/09/2017 Q2 -- -- -- -- --
05/15/2017 Q1 -- -- -- -- --
03/07/2017 Q4 -- -- -- -- --
11/07/2016 Q3 -- -- -- -- --
08/09/2016 Q2 -- -- -- -- --
05/16/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -- -- --
06/30/2015 Q2 -- -- -- -- --
03/31/2015 Q1 -- -- -- -- --
12/31/2014 Q4 -- -- -- -- --

Editas Medicine Earnings Questions

  • How Much did Editas Medicine Generate in Revenue Last Quarter?

    Editas Medicine reported $61K worth of top line sales in its most recent quarter.

  • Did Editas Medicine Beat Earnings Last Quarter?

    Editas Medicine announced earnings per share of -$0.75 which represents a beat of analyst forecast a -$0.77 per share.

  • Is Editas Medicine Profitable?

    Editas Medicine reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Editas Medicine EPS Next Year?

    Editas Medicine's earnings are forecast to decrease from -$2.02 per share to -$2.27 per share next year representing a decrease of -33.42%.

  • When is Editas Medicine's Earnings Date?

    Editas Medicine's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 0.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.55% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock